For adults aged 18 years and above, the JCVI’s advised vaccines include Moderna’s mRNA (Spikevax) bivalent Omicron BA.1/original wild-type vaccine, as well as its mRNA (Spikevax) original wild-type vaccine.
The Pfizer/BioNTech mRNA (Comirnaty) original wild-type vaccine is also advised, and in exceptional circumstances, the Novavax Matrix-M adjuvanted wild-type vaccine (Nuvaxovid) when ‘no alternative clinically suitable UK-approved COVID-19 vaccine is available,’ the JCVI stated.